SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
洋洋
Lv1
1
60 积分
2023-02-21 加入
最近求助
最近应助
互助留言
Ceftolozane/tazobactam for difficult‐to‐treat Gram‐negative infections: A real‐world tertiary hospital experience
6分钟前
求助中
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: resistance mechanisms and synergistic activity
1小时前
已完结
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies
1小时前
已完结
The safety of ceftolozane/tazobactam for the treatment of complicated urinary tract infections
3小时前
已完结
Malignancy risk in patients with atopic dermatitis: a population-based cohort study
5个月前
已完结
Mycosis fungoides and Sézary syndrome following dupilumab treatment: experience of two Italian tertiary care centres
5个月前
已完结
Dupilumab, Atopic Dermatitis, and Mycosis Fungoides—New Insights on an Evolving Story
5个月前
已完结
The association of atopic dermatitis and cutaneous T‐cell lymphoma: A multicentre cohort study
5个月前
已完结
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
6个月前
已完结
Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study
7个月前
已完结
没有进行任何应助
下到了【积分已退回】
9个月前
用不上了【积分已退回】
11个月前
这个是正文,不是补充材料
11个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论